000142620 001__ 142620
000142620 005__ 20240229105149.0
000142620 037__ $$aDKFZ-2019-00337
000142620 1001_ $$0P:(DE-He78)5b1cf0d83bf916d61a1ded34f2946b33$$aAnker, Sophie$$b0$$gfemale$$udkfz
000142620 245__ $$a 	Expression of Artificial microRNA by Oncolytic Measles Virus - a New Strategy to Overcome Resistance Mechanisms and Enhance Tumour Cell Killing
000142620 260__ $$c2018
000142620 3367_ $$2DataCite$$aOutput Types/Dissertation
000142620 3367_ $$2ORCID$$aDISSERTATION
000142620 3367_ $$2BibTeX$$aPHDTHESIS
000142620 3367_ $$02$$2EndNote$$aThesis
000142620 3367_ $$0PUB:(DE-HGF)11$$2PUB:(DE-HGF)$$aDissertation / PhD Thesis$$bphd$$mphd$$s1550496706_708
000142620 3367_ $$2DRIVER$$adoctoralThesis
000142620 502__ $$aDissertation, Universität Heidelberg, 2018$$bDissertation$$cUniversität Heidelberg$$gMedizinische Fakultät Heidelberg
000142620 536__ $$0G:(DE-HGF)POF3-317$$a317 - Translational cancer research (POF3-317)$$cPOF3-317$$fPOF III$$x0
000142620 909CO $$ooai:inrepo02.dkfz.de:142620$$pVDB
000142620 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)5b1cf0d83bf916d61a1ded34f2946b33$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000142620 9131_ $$0G:(DE-HGF)POF3-317$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vTranslational cancer research$$x0
000142620 9141_ $$y2018
000142620 9201_ $$0I:(DE-He78)G100-20160331$$kG100$$lTranslationale Onkologie$$x0
000142620 980__ $$aphd
000142620 980__ $$aVDB
000142620 980__ $$aI:(DE-He78)G100-20160331
000142620 980__ $$aUNRESTRICTED